Haohai Shengke: Shareholder Lou Guoliang reduces holdings by 774,700 shares, cashing out 28.9832 million yuan.

Haohai Life Sciences announced that shareholder Lou Guoliang, due to his own capital needs, had originally planned to reduce his holdings through centralized bidding and block trading from February 26 to May 25, 2026, totaling no more than 1 million shares, accounting for no more than 0.4337% of the total share capital. As of May 25, he had already sold a total of 774,725 shares through centralized bidding, accounting for 0.3369% of the current total share capital, at a selling price of 34.60 - 39.79 yuan/share, with a total selling amount of 28.9832 million yuan. He has yet to sell 225,275 shares, and his current shareholding ratio has decreased to 2.7591%.